Healthcare Biosimilars: FDA intervenes to address pervasive challenge of patent web with new Purple Book disclosure requirement sgblog Feb 2, 2021 0
Healthcare COVID-19 vaccines: Global collaborations & concerted scientific effort sets record benchmark for pace of development sgblog Jan 4, 2021 0
Healthcare Lackluster year for biosimilars – marked by regulatory and development delays sgblog Jan 4, 2021 0
Healthcare Patient friendly drug delivery – Adapting to the new normal & sustainable impact sgblog Jan 4, 2021 0
Healthcare Finally, long overdue focus on manufacturing resilience across geographic borders sgblog Jan 4, 2021 0
Healthcare 12 COVID19 vaccines across the globe crossing Phase III – Greater hope for widespread access? sgblog Nov 30, 2020 0
